Free Virtual Consultations. Corona Virus Related Cases Click Here.

Christopher Gilpineda Killed in Crash on 10 Freeway Near Kellogg Drive

1 Vehicle Rear-Ends Another in Fatal Pomona Accident 

Pomona, CA (April 11, 2020) – A man was killed in a rear-end crash in Pomona. The fatal accident occurred on the evening of April 11 on the 10 Freeway.

Christopher Gilpineda, 21, of Montebello, suffered a flat tire. He stopped his Honda Accord on the westbound 10 Freeway, near Kellogg Drive. A Honda Civic approached and rear-ended the Accord. The vehicle also hit Gilpineda, who was standing next to his car. He died at the accident scene.

Our heartfelt condolences go out to the friends and loved ones of Christopher Gilpineda.



May 1, 2020

Pedestrian Injured in Crash on Interstate 805 Near Imperial Avenue

Victim Hit by Car in San Diego Accident...

March 13, 2020

Ismael Arrenaviz Killed in Crash at Union Avenue and Columbus Street

Sleeping Driver Hits Bicyclist in Fatal Bakersfield Accident...

November 5, 2019

Bicyclist Killed in Crash on South Newhope Street

Man Hit by Car in Fatal Santa Ana Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post

May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.

May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.